Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study).

Isla D, De Las Peñas R, Insa A, Marsé R, Martínez-Banaclocha N, Mut P, Morán T, Sala MÁ, Massuti B, Ortega AL, Jurado JM, Gómez-Codina J, Diz P, Artal Á, Gutiérrez V, Vázquez MF, Viñolas N, Maestu I, Camps C, Álvarez R, de Mon Soto MÁ, Ponce S, Provencio M.

Lung Cancer. 2019 Sep;135:161-168. doi: 10.1016/j.lungcan.2018.11.041. Epub 2018 Dec 1.

PMID:
31446990
2.

Trained dogs can identify malignant solitary pulmonary nodules in exhaled gas.

Guirao A, Molins L, Ramón I, Sunyer G, Viñolas N, Marrades R, Sánchez D, Fibla JJ, Boada M, Hernández J, Guzmán R, Libreros A, Gómez-Caro A, Guerrero C, Agustí A.

Lung Cancer. 2019 Sep;135:230-233. doi: 10.1016/j.lungcan.2019.06.008. Epub 2019 Jun 15.

PMID:
31235316
3.

Clinical significance of long non-coding RNA HOTTIP in early-stage non-small-cell lung cancer.

Navarro A, Moises J, Santasusagna S, Marrades RM, Viñolas N, Castellano JJ, Canals J, Muñoz C, Ramírez J, Molins L, Monzo M.

BMC Pulm Med. 2019 Feb 28;19(1):55. doi: 10.1186/s12890-019-0816-8.

4.

Exosome Analysis in Tumor-Draining Pulmonary Vein Identifies NSCLC Patients with Higher Risk of Relapse after Curative Surgery.

Navarro A, Molins L, Marrades RM, Moises J, Viñolas N, Morales S, Canals J, Castellano JJ, Ramírez J, Monzo M.

Cancers (Basel). 2019 Feb 21;11(2). pii: E249. doi: 10.3390/cancers11020249.

5.

Lung cancer in Spanish women: The WORLD07 project.

Garrido P, Viñolas N, Isla D, Provencio M, Majem M, Artal A, Carcereny E, Garcia Campelo R, Lianes P, De La Peñas R, Felip E.

Eur J Cancer Care (Engl). 2019 Jan;28(1):e12941. doi: 10.1111/ecc.12941. Epub 2018 Oct 2.

PMID:
30277293
6.

Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types.

Paré L, Pascual T, Seguí E, Teixidó C, Gonzalez-Cao M, Galván P, Rodríguez A, González B, Cuatrecasas M, Pineda E, Torné A, Crespo G, Martin-Algarra S, Pérez-Ruiz E, Reig Ò, Viladot M, Font C, Adamo B, Vidal M, Gaba L, Muñoz M, Victoria I, Ruiz G, Viñolas N, Mellado B, Maurel J, Garcia-Corbacho J, Molina-Vila MÁ, Juan M, Llovet JM, Reguart N, Arance A, Prat A.

Ann Oncol. 2018 Oct 1;29(10):2121-2128. doi: 10.1093/annonc/mdy335.

PMID:
30165419
7.

NKX2-1 expression as a prognostic marker in early-stage non-small-cell lung cancer.

Moisés J, Navarro A, Santasusagna S, Viñolas N, Molins L, Ramirez J, Osorio J, Saco A, Castellano JJ, Muñoz C, Morales S, Monzó M, Marrades RM.

BMC Pulm Med. 2017 Dec 13;17(1):197. doi: 10.1186/s12890-017-0542-z.

8.

Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisions.

Mayo-de-Las-Casas C, Jordana-Ariza N, Garzón-Ibañez M, Balada-Bel A, Bertrán-Alamillo J, Viteri-Ramírez S, Reguart N, Muñoz-Quintana MA, Lianes-Barragan P, Camps C, Jantús E, Remon-Massip J, Calabuig S, Aguiar D, Gil ML, Viñolas N, Santos-Rodríguez AK, Majem M, García-Peláez B, Villatoro S, Pérez-Rosado A, Monasterio JC, Ovalle E, Catalán MJ, Campos R, Morales-Espinosa D, Martínez-Bueno A, González-Cao M, González X, Moya-Horno I, Sosa AE, Karachaliou N, Rosell R, Molina-Vila MA.

Ann Oncol. 2017 Sep 1;28(9):2248-2255. doi: 10.1093/annonc/mdx288.

PMID:
28911086
9.

Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database.

Remon J, Isla D, Garrido P, de Castro J, Majem M, Viñolas N, Artal A, Carcereny E, García-Campelo MR, Lianes P, Provencio M, Juan O, Diz P, Blanco R, Lopez-Castro R, Maestu I, Vadell C, Felip E.

Clin Transl Oncol. 2017 Dec;19(12):1537-1542. doi: 10.1007/s12094-017-1700-8. Epub 2017 Jun 28.

PMID:
28660482
10.

Immune-Related Gene Expression Profiling After PD-1 Blockade in Non-Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma.

Prat A, Navarro A, Paré L, Reguart N, Galván P, Pascual T, Martínez A, Nuciforo P, Comerma L, Alos L, Pardo N, Cedrés S, Fan C, Parker JS, Gaba L, Victoria I, Viñolas N, Vivancos A, Arance A, Felip E.

Cancer Res. 2017 Jul 1;77(13):3540-3550. doi: 10.1158/0008-5472.CAN-16-3556. Epub 2017 May 9.

11.

Lung Cancer in Never-Smoking Women: A Sub-Analysis of the Spanish Female-Specific Database WORLD07.

Viñolas N, Garrido P, Isla D, Provencio M, Majem M, Artal A, Carcereny E, Garcia Campelo R, Lianes P, De La Peñas R, Felip E.

Cancer Invest. 2017 May 28;35(5):358-365. doi: 10.1080/07357907.2017.1295461. Epub 2017 Mar 28.

PMID:
28350480
12.

Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer Patients.

Reguart N, Teixidó C, Giménez-Capitán A, Paré L, Galván P, Viteri S, Rodríguez S, Peg V, Aldeguer E, Viñolas N, Remon J, Karachaliou N, Conde E, Lopez-Rios F, Nadal E, Merkelbach-Bruse S, Büttner R, Rosell R, Molina-Vila MA, Prat A.

Clin Chem. 2017 Mar;63(3):751-760. doi: 10.1373/clinchem.2016.265314. Epub 2017 Jan 10.

13.

Lung Cancer in Women with a Family History of Cancer: The Spanish Female-specific Database WORLD07.

Isla D, Felip E, Viñolas N, Provencio M, Majem M, Artal A, Bover I, Lianes P, DE Las Peñas R, Catot S, DE Castro J, Blasco A, Terrasa J, Gonzalez-Larriba JL, Juan O, Dómine M, Bernabe R, Garrido P.

Anticancer Res. 2016 Dec;36(12):6647-6653.

PMID:
27919997
14.

A consensus statement on the gender perspective in lung cancer.

Isla D, Majem M, Viñolas N, Artal A, Blasco A, Felip E, Garrido P, Remón J, Baquedano M, Borrás JM, Die Trill M, García-Campelo R, Juan O, León C, Lianes P, López-Ríos F, Molins L, Planchuelo MÁ, Cobo M, Paz-Ares L, Trigo JM, de Castro J.

Clin Transl Oncol. 2017 May;19(5):527-535. doi: 10.1007/s12094-016-1578-x. Epub 2016 Nov 24. Review.

PMID:
27885542
15.

LincRNA-p21 Impacts Prognosis in Resected Non-Small Cell Lung Cancer Patients through Angiogenesis Regulation.

Castellano JJ, Navarro A, Viñolas N, Marrades RM, Moises J, Cordeiro A, Saco A, Muñoz C, Fuster D, Molins L, Ramirez J, Monzo M.

J Thorac Oncol. 2016 Dec;11(12):2173-2182. doi: 10.1016/j.jtho.2016.07.015. Epub 2016 Aug 2.

16.

YKT6 expression, exosome release, and survival in non-small cell lung cancer.

Ruiz-Martinez M, Navarro A, Marrades RM, Viñolas N, Santasusagna S, Muñoz C, Ramírez J, Molins L, Monzo M.

Oncotarget. 2016 Aug 9;7(32):51515-51524. doi: 10.18632/oncotarget.9862.

17.

Feasibility, tolerability, and efficacy of the concurrent addition of erlotinib to thoracic radiotherapy in locally advanced unresectable non-small-cell lung cancer: a Phase II trial.

Martínez E, Martínez M, Rico M, Hernández B, Casas F, Viñolas N, Pérez-Casas A, Dómine M, Mínguez J.

Onco Targets Ther. 2016 Mar 1;9:1057-66. doi: 10.2147/OTT.S89755. eCollection 2016.

18.

A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer.

Schmid-Bindert G, Engel-Riedel W, Reck M, Schuette W, Stöhlmacher J, Fischer JR, Mazières J, Chouaid C, Wolf M, Vinolas N, Soldatenkova V, Ripoche V, Nguyen T, Visseren-Grul C.

Lung Cancer. 2015 Dec;90(3):397-404. doi: 10.1016/j.lungcan.2015.11.007. Epub 2015 Nov 7.

PMID:
26791798
19.

SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015.

García-Campelo R, Bernabé R, Cobo M, Corral J, Coves J, Dómine M, Nadal E, Rodriguez-Abreu D, Viñolas N, Massuti B.

Clin Transl Oncol. 2015 Dec;17(12):1020-9. doi: 10.1007/s12094-015-1455-z. Epub 2015 Dec 21.

20.

Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer.

Molina R, Marrades RM, Augé JM, Escudero JM, Viñolas N, Reguart N, Ramirez J, Filella X, Molins L, Agustí A.

Am J Respir Crit Care Med. 2016 Feb 15;193(4):427-37. doi: 10.1164/rccm.201404-0603OC.

PMID:
26465739
21.

Successful Oral Desensitization in a Patient With Hypersensitivity Reaction to Crizotinib.

Sánchez-López J, Viñolas N, Muñoz-Cano R, Pascal M, Reguart N, Bartra J, Valero A.

J Investig Allergol Clin Immunol. 2015;25(4):307-8. No abstract available.

22.

The significance of PIWI family expression in human lung embryogenesis and non-small cell lung cancer.

Navarro A, Tejero R, Viñolas N, Cordeiro A, Marrades RM, Fuster D, Caritg O, Moises J, Muñoz C, Molins L, Ramirez J, Monzo M.

Oncotarget. 2015 Oct 13;6(31):31544-56. doi: 10.18632/oncotarget.3003.

23.

Assessment of ALK status by FISH on 1000 Spanish non-small cell lung cancer patients.

Vidal J, Clavé S, de Muga S, González I, Pijuan L, Gimeno J, Remón J, Reguart N, Viñolas N, Gironés R, Bernet L, Majem M, Bosch-Barrera J, Porta R, Alonso N, Palmero R, Taus A, Albanell J, Espinet B, Salido M, Arriola E.

J Thorac Oncol. 2014 Dec;9(12):1816-20. doi: 10.1097/JTO.0000000000000361.

24.

miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma.

Tejero R, Navarro A, Campayo M, Viñolas N, Marrades RM, Cordeiro A, Ruíz-Martínez M, Santasusagna S, Molins L, Ramirez J, Monzó M.

PLoS One. 2014 Jul 8;9(7):e101899. doi: 10.1371/journal.pone.0101899. eCollection 2014.

25.

A randomised phase II study of pemetrexed versus pemetrexed+erlotinib as second-line treatment for locally advanced or metastatic non-squamous non-small cell lung cancer.

Dittrich C, Papai-Szekely Z, Vinolas N, Sederholm C, Hartmann JT, Behringer D, Kazeem G, Desaiah D, Leschinger MI, von Pawel J.

Eur J Cancer. 2014 Jun;50(9):1571-80. doi: 10.1016/j.ejca.2014.03.007. Epub 2014 Apr 2.

PMID:
24703574
26.

Lung cancer in women: an overview with special focus on Spanish women.

Remon J, Molina-Montes E, Majem M, Lianes P, Isla D, Garrido P, Felip E, Viñolas N, de Castro J, Artal A, Sánchez MJ.

Clin Transl Oncol. 2014 Jun;16(6):517-28. doi: 10.1007/s12094-013-1137-7. Epub 2013 Nov 26. Review.

PMID:
24277573
27.

Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary.

Provencio M, Sánchez A, Artal A, Sánchez Torres JM, García Gómez R, Constenla M, de Castro J, Dómine M, Viñolas N, Sánchez A, Pérez FJ.

Clin Transl Oncol. 2013 Aug;15(8):659-64. doi: 10.1007/s12094-012-0989-6. Epub 2013 Jan 29. Erratum in: Clin Transl Oncol. 2013 Aug;15(8):670. García Gómez, Ramón [added]; Constenla, Manuel [added].

PMID:
23359178
28.

Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer.

Campayo M, Navarro A, Viñolas N, Diaz T, Tejero R, Gimferrer JM, Molins L, Cabanas ML, Ramirez J, Monzo M, Marrades R.

Eur Respir J. 2013 May;41(5):1172-8. doi: 10.1183/09031936.00048712. Epub 2012 Jul 26.

29.

Sleeve lobectomy after induction chemoradiotherapy.

Gómez-Caro A, Boada M, Reguart N, Viñolas N, Casas F, Molins L.

Eur J Cardiothorac Surg. 2012 May;41(5):1052-8. doi: 10.1093/ejcts/ezr184. Epub 2012 Jan 4.

PMID:
22223693
30.

Trabectedin in patients with advanced non-small-cell lung cancer (NSCLC) with XPG and/or ERCC1 overexpression and BRCA1 underexpression and pretreated with platinum.

Massuti B, Cobo M, Camps C, Dómine M, Provencio M, Alberola V, Viñolas N, Rosell R, Tarón M, Gutiérrez-Calderón V, Lardelli P, Alfaro V, Nieto A, Isla D.

Lung Cancer. 2012 Jun;76(3):354-61. doi: 10.1016/j.lungcan.2011.12.002. Epub 2011 Dec 23.

PMID:
22197612
31.

Does gender matter in glioblastoma?

Verger E, Valduvieco I, Caral L, Pujol T, Ribalta T, Viñolas N, Boget T, Oleaga L, Blanco Y, Graus F.

Clin Transl Oncol. 2011 Oct;13(10):737-41. doi: 10.1007/s12094-011-0725-7.

PMID:
21975336
32.

SEOM guidelines on thrombosis in cancer patients.

Muñoz AJ, Viñolas N, Cubedo R, Isla D.

Clin Transl Oncol. 2011 Aug;13(8):592-6. doi: 10.1007/s12094-011-0703-0.

PMID:
21821496
33.

A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma.

Campayo M, Navarro A, Viñolas N, Tejero R, Muñoz C, Diaz T, Marrades R, Cabanas ML, Gimferrer JM, Gascon P, Ramirez J, Monzo M.

PLoS One. 2011;6(7):e22509. doi: 10.1371/journal.pone.0022509. Epub 2011 Jul 25.

34.

[Implication of radiological pattern in the prognosis of oligodendroglial tumors: correlation with genetic profile].

Brell M, Castañer S, Pujol-Farré T, Boluda S, Ribalta T, Bruna J, Martínez M, Verger E, Villà S, Viñolas N, Gil M, Graus F, Tortosa-Moreno A.

Rev Neurol. 2011 Apr 16;52(8):465-71. Spanish.

35.

Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer.

Navarro A, Diaz T, Gallardo E, Viñolas N, Marrades RM, Gel B, Campayo M, Quera A, Bandres E, Garcia-Foncillas J, Ramirez J, Monzo M.

J Surg Oncol. 2011 Apr;103(5):411-5. doi: 10.1002/jso.21847. Epub 2010 Dec 29.

PMID:
21400525
36.

Single nucleotide polymorphisms in tobacco metabolism and DNA repair genes and prognosis in resected non-small-cell lung cancer.

Campayo M, Viñolas N, Navarro A, Carcereny E, Casas F, Gel B, Diaz T, Gimferrer JM, Marrades RM, Ramirez J, Monzo M.

J Surg Res. 2011 May 1;167(1):e5-12. doi: 10.1016/j.jss.2011.01.007. Epub 2011 Feb 2.

PMID:
21324488
37.

Long-term results of a phase II trial of induction paclitaxel-carboplatin followed by concurrent radiation therapy and weekly paclitaxel and consolidation paclitaxel-carboplatin in stage III non-small cell lung cancer.

Casas F, Viñolas N, Ferrer F, Agustí C, Sanchez M, Maria Gimferrer J, Lomeña F, Campayo M, Jeremic B.

J Thorac Oncol. 2011 Jan;6(1):79-85. doi: 10.1097/JTO.0b013e318200e563.

38.

Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine.

Viñolas N, Provencio M, Reguart N, Cardenal F, Alberola V, Sánchez-Torres JM, Barón FJ, Cobo M, Maestu I, Moreno I, Mesía C, Izquierdo A, Felip E, López-Brea M, Márquez A, Sánchez-Ronco M, Tarón M, Santarpia MC, Rosell R; Spanish Lung Cancer Group.

Lung Cancer. 2011 Feb;71(2):191-8. doi: 10.1016/j.lungcan.2010.05.005.

PMID:
20627363
39.

miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.

Gallardo E, Navarro A, Viñolas N, Marrades RM, Diaz T, Gel B, Quera A, Bandres E, Garcia-Foncillas J, Ramirez J, Monzo M.

Carcinogenesis. 2009 Nov;30(11):1903-9. doi: 10.1093/carcin/bgp219. Epub 2009 Sep 7.

PMID:
19736307
40.

Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain.

Mayordomo JI, López A, Viñolas N, Castellanos J, Pernas S, Domingo Alonso J, Frau A, Layola M, Antonio Gasquet J, Sánchez J; ENIA Study Group.

Curr Med Res Opin. 2009 Oct;25(10):2533-42. doi: 10.1185/03007990903209563.

PMID:
19722781
41.

Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology.

Molina R, Augé JM, Bosch X, Escudero JM, Viñolas N, Marrades R, Ramírez J, Carcereny E, Filella X.

Tumour Biol. 2009;30(3):121-9. doi: 10.1159/000224628. Epub 2009 Jun 9.

PMID:
19506400
42.

MicroRNAs expressed during lung cancer development are expressed in human pseudoglandular lung embryogenesis.

Navarro A, Marrades RM, Viñolas N, Quera A, Agustí C, Huerta A, Ramirez J, Torres A, Monzo M.

Oncology. 2009;76(3):162-9. doi: 10.1159/000201569. Epub 2009 Feb 11.

PMID:
19209007
43.

Lung cancer and treatment in elderly patients: the Achilles Study.

Provencio M, Camps C, Alberola V, Massutti B, Viñolas N, Isla D, Dómine M, Millán I, Cobo M, Rosell R.

Lung Cancer. 2009 Oct;66(1):103-6. doi: 10.1016/j.lungcan.2008.12.021. Epub 2009 Feb 4.

PMID:
19193470
44.

Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSE.

Molina R, Auge JM, Escudero JM, Marrades R, Viñolas N, Carcereny E, Ramirez J, Filella X.

Tumour Biol. 2008;29(6):371-80. doi: 10.1159/000181180. Epub 2008 Dec 8.

PMID:
19060513
45.

Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancer.

Cobo M, Isla D, Massuti B, Montes A, Sanchez JM, Provencio M, Viñolas N, Paz-Ares L, Lopez-Vivanco G, Muñoz MA, Felip E, Alberola V, Camps C, Domine M, Sanchez JJ, Sanchez-Ronco M, Danenberg K, Taron M, Gandara D, Rosell R.

J Clin Oncol. 2007 Jul 1;25(19):2747-54.

PMID:
17602080
46.

Spanish patterns of care for 3D radiotherapy in non-small-cell lung cancer.

Casas F, Viñolas N, Sanchez-Reyes A, Jorcano S, Planas I, Marruecos J, Pino F, Herreros A, Biete A.

Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):138-42.

PMID:
16618576
47.

Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial.

Camps C, Massuti B, Jiménez A, Maestu I, Gómez RG, Isla D, González JL, Almenar D, Blasco A, Rosell R, Carrato A, Viñolas N, Batista N, Girón CG, Galán A, López M, Blanco R, Provencio M, Diz P, Felip E; Spanish Lung Cancer Group.

Ann Oncol. 2006 Mar;17(3):467-72. Epub 2005 Dec 21.

PMID:
16371411
48.

Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas.

Brell M, Tortosa A, Verger E, Gil JM, Viñolas N, Villá S, Acebes JJ, Caral L, Pujol T, Ferrer I, Ribalta T, Graus F.

Clin Cancer Res. 2005 Jul 15;11(14):5167-74.

49.

Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.

Molina R, Auge JM, Filella X, Viñolas N, Alicarte J, Domingo JM, Ballesta AM.

Anticancer Res. 2005 May-Jun;25(3A):1773-8.

50.

Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial.

Verger E, Gil M, Yaya R, Viñolas N, Villà S, Pujol T, Quintó L, Graus F.

Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):185-91.

PMID:
15629610

Supplemental Content

Loading ...
Support Center